Established in 1982, Mega Lifesciences public company limited is actively involved in helping millions of people have access to safe, effective, world-class quality nutritional & herbal supplements, and medications. Mega strives to help people stay healthy as long as they live.
CORPORATE OVERVIEW
From Thailand to the world, Mega is engaged in manufacturing, marketing, selling and distributing quality pharmaceutical, nutraceutical products and Fast Moving Consumer Goods (FMCG). Our manufacturing facilities located in Thailand & Australia, have received international accreditation from reputed health authorities around the world with respect to good manufacturing practices. We export to Asia-Pacific, Middle East, Africa, CIS-Countries, Latin America and Europe. Our business activities across all major stages of the pharmaceutical industry value chain provide us with increased opportunities to pursue growth by realizing potential synergies arising from coordinating our efforts across business segments in our selected markets.
OUR BUSINESSES
As a leader and pioneer in the health and wellness industry across the globe, we at MEGA strive to be more than just a provider of goods and services. Through our efforts, we offer people a chance at a better, healthier life. Whether that’s through our internally developed pharmaceuticals, our manufacturing arm, or our lines of supplements and nutraceuticals, we endeavour to bring good health back to the community.
Maxxcare is our distribution business under which we market, sell, and distribute a variety of branded prescription pharmaceuticals, as well as OTC and FMCG products.
Our services include warehouse management, collections, and value-adds such as marketing services for major principals. We operate in Myanmar, Vietnam and Cambodia.
We also achieved our goal to be listed among the ESG companies in Thailand, and have progressed well, to be included in the this index. we continue to build on our sustainability
Our Achievements
IR Magazine Award - South East Asia 2023 Best IR website
Award Winner South East Asia 2023
THSI 2022
MEGA has been selected as a member of THSI 2022 as a sustainable stock.
Forbes Asia Best Under A Billion 2022
Mega has been retained as part of the latest Forbes Best in Asia 2022 list of Companies. The listing recognizes the best 200 companies from amongst 20,000 listed companies in the Asia-Pacific region with sales under US$1 billion. Selection criteria include consistent and sustainable value creation potential, good corporate governance practices, quality of management etc. To view full list, please visit www.forbes.com/bub.
THE FUTURE OF OUR PAST AND PRESENT
